Brian G. Feagan
Western University(CA)Alion Science and Technology (United States)(US)London Health Sciences Centre(CA)Align Technology (United States)(US)University Gastroenterology(US)University College London(GB)University of Cincinnati Medical Center(US)Western University of Health Sciences(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Autoimmune and Inflammatory Disorders, Immunodeficiency and Autoimmune Disorders
Most-Cited Works
- → Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial(2002)4,145 cited
- → Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis(2005)3,852 cited
- → Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis(2013)2,800 cited
- → Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease(2013)2,657 cited
- → Infliximab Maintenance Therapy for Fistulizing Crohn's Disease(2004)2,201 cited
- → Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target(2015)1,802 cited